Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	TTF2 DNAH3 ATP6V1C1 MYH7 MYO1C KIF1A MYO5A DYNC2H1 TMEM94 DHX37 MCM7 CHD7 BTAF1 ABCA8 KIF2B ABCA6 SMARCA1 NAV2 ATP6V1C2 DDX60L ATP1A4 HSP90AA1	4.23e-08	614	181	22	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	DNAH3 MYH7 KIF1A DYNC2H1 DHX37 MCM7 CHD7 BTAF1 ABCA8 KIF2B ABCA6 NAV2 DDX60L ATP1A4 HSP90AA1	1.25e-05	441	181	15	GO:0016887
GeneOntologyMolecularFunction	pyrophosphatase activity	DNAH3 MYH7 KIF1A DYNC2H1 DHX37 MCM7 CHD7 BTAF1 ABCA8 OPA1 ARHGDIB NUDT3 KIF2B ABCA6 GPN2 RHOBTB2 NAV2 RASEF DDX60L ATP1A4 HSP90AA1	2.53e-05	839	181	21	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	DNAH3 MYH7 KIF1A DYNC2H1 DHX37 MCM7 CHD7 BTAF1 ABCA8 OPA1 ARHGDIB NUDT3 KIF2B ABCA6 GPN2 RHOBTB2 NAV2 RASEF DDX60L ATP1A4 HSP90AA1	2.58e-05	840	181	21	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	DNAH3 MYH7 KIF1A DYNC2H1 DHX37 MCM7 CHD7 BTAF1 ABCA8 OPA1 ARHGDIB NUDT3 KIF2B ABCA6 GPN2 RHOBTB2 NAV2 RASEF DDX60L ATP1A4 HSP90AA1	2.58e-05	840	181	21	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	DNAH3 MYH7 KIF1A DYNC2H1 DHX37 MCM7 CHD7 BTAF1 ABCA8 OPA1 ARHGDIB KIF2B ABCA6 GPN2 RHOBTB2 NAV2 RASEF DDX60L ATP1A4 HSP90AA1	2.60e-05	775	181	20	GO:0017111
GeneOntologyMolecularFunction	helicase activity	TTF2 DHX37 MCM7 CHD7 BTAF1 SMARCA1 NAV2 DDX60L	9.89e-05	158	181	8	GO:0004386
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 MYH7 MYO1C KIF1A MYO5A DYNC2H1 KIF2B	1.01e-04	118	181	7	GO:0003774
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	TTF2 CHD7 BTAF1 SMARCA1	3.41e-04	37	181	4	GO:0140658
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ATP6V1C1 TMEM94 ABCA8 ABCA6 ATP6V1C2 ATP1A4	4.78e-04	109	181	6	GO:0042626
GeneOntologyMolecularFunction	kinase binding	DSCAM MYO5A PIWIL1 SREBF1 OPA1 PTPN5 WDR45 KIDINS220 SIPA1L1 RHOBTB2 GOLGA8B PRKCB TRPV4 ZFYVE26 CCR5 EXOC2 ATP1A4 GOLGA8A BANK1 HSP90AA1	5.18e-04	969	181	20	GO:0019900
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	TTF2 ERCC4 DHX37 PIWIL1 MCM7 CHD7 BTAF1 DIS3 METTL25B TRNT1 SARS2 SMARCA1 NAV2 DDX60L NIPBL	8.15e-04	645	181	15	GO:0140640
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	DSCAM KIF1A KALRN NTRK3 ICAM1 TRPC6 TBC1D2B ID1 THOC2 OPA1 PTPN5 KIDINS220 SIPA1L1 CEP135 GOLGA8B TRPV4 CCR5 SGSM3 MAP2K2 GOLGA8A HSP90AA1 HDAC2	3.69e-06	846	177	22	GO:0120035
GeneOntologyBiologicalProcess	regulation of cell projection organization	DSCAM KIF1A KALRN NTRK3 ICAM1 TRPC6 TBC1D2B ID1 THOC2 OPA1 PTPN5 KIDINS220 SIPA1L1 CEP135 GOLGA8B TRPV4 CCR5 SGSM3 MAP2K2 GOLGA8A HSP90AA1 HDAC2	5.07e-06	863	177	22	GO:0031344
GeneOntologyBiologicalProcess	organelle assembly	MYH7 EDC3 RPGRIP1L DYNC2H1 DHX37 USP9X NTRK3 TTLL5 TBC1D2B RFX2 EHD2 FSIP2 NCOR1 NEK2 WDR45 SIPA1L1 CEP135 GOLGA8B TEKT1 GABARAPL3 SGSM3 PLEC GOLGA8A WDR62 HDAC2	1.46e-05	1138	177	25	GO:0070925
GeneOntologyBiologicalProcess	macroautophagy	ATP6V1C1 MYO5A RIPK2 SREBF1 WDR45 VPS13D ADRB2 PIK3C2A ZFYVE26 ATP6V1C2 GABARAPL3 WDFY3 RUBCN	2.19e-05	374	177	13	GO:0016236
GeneOntologyBiologicalProcess	regulation of neuron projection development	DSCAM KIF1A KALRN NTRK3 TRPC6 ID1 THOC2 OPA1 PTPN5 KIDINS220 SIPA1L1 GOLGA8B TRPV4 CCR5 MAP2K2 GOLGA8A HDAC2	2.20e-05	612	177	17	GO:0010975
GeneOntologyBiologicalProcess	process utilizing autophagic mechanism	ATP6V1C1 ERCC4 MYO5A RIPK2 SREBF1 WDR45 VPS13D ADRB2 PIK3C2A GOLGA8B ZFYVE26 ATP6V1C2 GABARAPL3 WDFY3 GOLGA8A RUBCN HSP90AA1	4.68e-05	650	177	17	GO:0061919
GeneOntologyBiologicalProcess	autophagy	ATP6V1C1 ERCC4 MYO5A RIPK2 SREBF1 WDR45 VPS13D ADRB2 PIK3C2A GOLGA8B ZFYVE26 ATP6V1C2 GABARAPL3 WDFY3 GOLGA8A RUBCN HSP90AA1	4.68e-05	650	177	17	GO:0006914
GeneOntologyBiologicalProcess	cell projection morphogenesis	DSCAM KIF1A TRIO KALRN USP9X NTRK3 TRPC6 ID1 LAMA3 SIN3A OPA1 KIDINS220 SIPA1L1 ITSN2 GOLGA8B CCR5 MAP2K2 GOLGA8A PACSIN2	9.26e-05	826	177	19	GO:0048858
GeneOntologyCellularComponent	microtubule	DNAH3 RPGRIP1L KIF1A DYNC2H1 TTLL5 HID1 OPA1 NEK2 KIF2B GOLGA8B TEKT1 TRPV4 GABARAPL3 MAP2K2 GOLGA8A	7.90e-05	533	184	15	GO:0005874
MousePheno	abnormal cortical ventricular zone morphology	THOC2 CEP135 SMARCA1 WDFY3 WDR62	3.68e-06	25	136	5	MP:0008458
Domain	P-loop_NTPase	TTF2 DNAH3 MYH7 MYO1C KIF1A MYO5A DYNC2H1 DHX37 MCM7 CHD7 BTAF1 NDUFA10 ABCA8 OPA1 AK8 EHD2 KIF2B ABCA6 GPN2 RHOBTB2 SMARCA1 NAV2 RASEF DDX60L	2.20e-06	848	180	24	IPR027417
Domain	ATPase_V1-cplx_csu	ATP6V1C1 ATP6V1C2	9.24e-05	2	180	2	IPR004907
Domain	V-ATPase_C	ATP6V1C1 ATP6V1C2	9.24e-05	2	180	2	PF03223
Domain	-	TTF2 DNAH3 DYNC2H1 DHX37 MCM7 CHD7 BTAF1 NDUFA10 ABCA8 OPA1 AK8 EHD2 ABCA6 GPN2 RHOBTB2 SMARCA1 NAV2 RASEF DDX60L	1.11e-04	746	180	19	3.40.50.300
Domain	SNF2_N	TTF2 CHD7 BTAF1 SMARCA1	2.43e-04	32	180	4	IPR000330
Domain	SNF2_N	TTF2 CHD7 BTAF1 SMARCA1	2.43e-04	32	180	4	PF00176
Domain	DEAH_ATP_HELICASE	TTF2 DHX37 CHD7 SMARCA1	4.77e-04	38	180	4	PS00690
Domain	Helicase_C	TTF2 DHX37 CHD7 BTAF1 SMARCA1 DDX60L	5.96e-04	107	180	6	PF00271
Domain	HELICc	TTF2 DHX37 CHD7 BTAF1 SMARCA1 DDX60L	5.96e-04	107	180	6	SM00490
Domain	-	TRIO KALRN ALS2CL ITSN2 ARHGEF37	6.12e-04	71	180	5	1.20.900.10
Domain	DH-domain	TRIO KALRN ALS2CL ITSN2 ARHGEF37	6.12e-04	71	180	5	IPR000219
Domain	Helicase_C	TTF2 DHX37 CHD7 BTAF1 SMARCA1 DDX60L	6.26e-04	108	180	6	IPR001650
Domain	RUN	SGSM1 SGSM3 RUBCN	6.46e-04	18	180	3	SM00593
Domain	HELICASE_CTER	TTF2 DHX37 CHD7 BTAF1 SMARCA1 DDX60L	6.57e-04	109	180	6	PS51194
Domain	HELICASE_ATP_BIND_1	TTF2 DHX37 CHD7 BTAF1 SMARCA1 DDX60L	6.57e-04	109	180	6	PS51192
Domain	DEXDc	TTF2 DHX37 CHD7 BTAF1 SMARCA1 DDX60L	6.57e-04	109	180	6	SM00487
Domain	Helicase_ATP-bd	TTF2 DHX37 CHD7 BTAF1 SMARCA1 DDX60L	6.90e-04	110	180	6	IPR014001
Domain	RUN	SGSM1 SGSM3 RUBCN	7.61e-04	19	180	3	PS50826
Domain	RUN	SGSM1 SGSM3 RUBCN	7.61e-04	19	180	3	PF02759
Domain	Run_dom	SGSM1 SGSM3 RUBCN	7.61e-04	19	180	3	IPR004012
Domain	Choline_transpo	SLC44A4 SLC44A5	9.06e-04	5	180	2	PF04515
Domain	Choline_transptr-like	SLC44A4 SLC44A5	9.06e-04	5	180	2	IPR007603
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ATP6V1C1 CAND1 ACADM DHX37 MCM7 CHD7 NUP214 HEATR1 NDUFA10 PRPF8 THOC2 APOBEC3B DIS3 GRSF1 OPA1 BAP1 NCOR1 TRNT1 RRP12 PRKCB PLEC MAP2K2 NIPBL HSP90AA1 HDAC2	3.54e-08	1318	184	25	30463901
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CUL2 EDC3 RPGRIP1L ERF DYNC2H1 EXOC3 MCM7 HEATR1 NDUFA10 PRPF8 DIS3 OPA1 PPP4R3A LRCH3 TAF6L TMEM120A SIPA1L1 NUP133 UQCC1 EXOC2 PLEC MUC5AC RUSF1 WDR62 HDAC2	3.70e-08	1321	184	25	27173435
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPP2 CAND1 DSCAM TRIO MYO5A KALRN USP9X HECTD4 RIPK2 CHD7 OPA1 NCOR1 WDR45 SIPA1L1 GOLGA8B PRKCB WDFY3 GOLGA8A NIPBL HSP90AA1 HDAC2	4.82e-08	963	184	21	28671696
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	CUL2 MYO1C ACADM ECD EXOC3 MCM7 SIN3A NDUFA10 PRPF8 OPA1 PPP4R3A NCOR1 NUP133 LSS EXOC2 HDAC2	5.79e-08	560	184	16	35241646
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPP2 MYO1C KIF1A MYO5A DHX37 USP9X CHD7 NUP214 HEATR1 PRPF8 THOC2 DIS3 RRP12 NUP133 PLEC NIPBL HDAC2	8.33e-08	653	184	17	22586326
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CAND1 DSCAM KIF1A TRIO MYO5A KALRN USP9X TTLL5 ZNF329 HECTD4 NFKBID ZFC3H1 NDUFA10 PRPF8 BFSP1 KANSL2 SARS2 SACS SIPA1L1 SGSM3 WDFY3 PLEC NIPBL HSP90AA1	9.08e-08	1285	184	24	35914814
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	DSCAM HEATR1 ZFC3H1 NDUFA10 PRPF8 THOC2 KIDINS220 PIK3C2A RRP12 MAP2K2	1.39e-07	202	184	10	24639526
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	TTF2 CAND1 MYO1C DYNC2H1 NUP214 HEATR1 DIS3 OPA1 VPS13D SARS2 KIDINS220 RRP12 SMARCA1 NUP133 EXOC2 WDR62	1.69e-07	606	184	16	36538041
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TTF2 CAND1 MYO1C MYO5A DHX37 EXOC3 MCM7 CHD7 NUP214 HEATR1 PRPF8 DIS3 GRSF1 RLF PIK3C2A RRP12 SMARCA1 NUP133 DDX60L WDFY3 EXOC2 PLEC NIPBL HSP90AA1	2.32e-07	1353	184	24	29467282
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CAND1 ACADM USP9X MCM7 NUP214 SIN3A HEATR1 PRPF8 THOC2 DIS3 PPP4R3A NUP133 PLEC MAP2K2 HSP90AA1 HDAC2	3.35e-07	638	184	16	33239621
Pubmed	Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.	TTF2 MYO1C USP9X MCM7 SIN3A PRPF8 THOC2 DIS3 RRP12	6.01e-07	182	184	9	32239614
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYO1C CHD7 BTAF1 NUP214 SIN3A THOC2 PPP4R3A BAP1 NCOR1 KANSL2 SIPA1L1 RRP12 EXOC2 PLEC MAP2K2 NIPBL WDR62	8.90e-07	774	184	17	15302935
Pubmed	Defining the membrane proteome of NK cells.	EDC3 CAND1 MYO1C MYO5A USP9X ICAM1 MARCHF6 MCM7 HEATR1 PRPF8 GOSR2 DIS3 OPA1 NCOR1 KIDINS220 PIK3C2A NUP133 LSS EXOC2 RUSF1 HSP90AA1	1.13e-06	1168	184	21	19946888
Pubmed	Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.	SIN3A NCOR1 HDAC2	1.45e-06	5	184	3	12634383
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LRRC8E TRPM4 NDOR1 ZNF585A TRIO KALRN TMEM94 HECTD4 SREBF1 BTAF1 NUP214 BAP1 NCOR1 SARS2 RRP12 SLC35A2 NAV2 ZFYVE26 WDFY3 PLEC	1.88e-06	1105	184	20	35748872
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	CAND1 TRIO MYO5A KALRN USP9X NTRK3 OPA1 SACS SIPA1L1 PRKCB	2.81e-06	281	184	10	28706196
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	CUL2 TPP2 EDC3 MYO1C USP9X NUP214 HEATR1 PRPF8 DIS3 PPP4R3A SACS RRP12 LSS	2.85e-06	498	184	13	36634849
Pubmed	FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.	SIN3A BAP1 NCOR1 HDAC2	3.44e-06	20	184	4	27773593
Pubmed	The functional interactome landscape of the human histone deacetylase family.	TTF2 ACADM USP9X SIN3A HEATR1 NDUFA10 NCOR1 RRP12 NUP133 HDAC2	3.61e-06	289	184	10	23752268
Pubmed	Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.	SIN3A NCOR1 HDAC2	5.02e-06	7	184	3	17956988
Pubmed	Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor.	SIN3A NCOR1 HSP90AA1	5.02e-06	7	184	3	17210713
Pubmed	Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth.	SIN3A NCOR1 HDAC2	5.02e-06	7	184	3	17182846
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TTF2 C14orf93 ERF POT1 SREBF1 CHD7 NUP214 SIN3A HEATR1 ZFC3H1 PRPF8 THOC2 BAP1 TAF6L NCOR1 KANSL2 TMTC3 RRP12 NUP133 NIPBL HDAC2	5.57e-06	1294	184	21	30804502
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CAND1 MYO1C KIF1A TRIO DYNC2H1 DHX37 USP9X ZNF329 MCM7 NUP214 HEATR1 NDUFA10 PRPF8 THOC2 DIS3 GRSF1 OPA1 KIDINS220 RRP12 SMARCA1 NUP133 NIPBL	7.22e-06	1425	184	22	30948266
Pubmed	Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance.	ICAM1 CCR5 CCR8	8.00e-06	8	184	3	32111837
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CUL2 EDC3 CAND1 MCM7 SIN3A PRPF8 THOC2 DIS3 PPP4R3A EHD2 TAF6L NCOR1 TRNT1 NUP133 PLEC NIPBL HSP90AA1 HDAC2	8.22e-06	1014	184	18	32416067
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	EPHX2 ATP6V1C1 CAND1 MYO1C KALRN DYNC2H1 VASN ICAM1 SLC44A4 CFI EHD2 ARHGDIB VPS13D PIK3C2A ITSN2 ATP6V1C2 NIPBL PACSIN2	8.44e-06	1016	184	18	19056867
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CUL2 TPP2 CAND1 MYO1C ACADM ECD MCM7 BTAF1 HEATR1 PRPF8 GOSR2 THOC2 DIS3 LRCH3 EHD2 PIK3C2A SIPA1L1 RRP12 NUP133 DDX60L EXOC2 HSP90AA1	8.51e-06	1440	184	22	30833792
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH7 MYO1C MYO5A ECD SANBR HEATR1 ZFC3H1 PRPF8 NCOR1 NEK2 TRNT1 SACS LMLN ITSN2 SMARCA1 NAV2 PLEC ATP1A4 CCDC191 NIPBL HSP90AA1 HDAC2	8.69e-06	1442	184	22	35575683
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TTF2 EDC3 CAND1 ECD BTAF1 NUP214 SIN3A HEATR1 PRPF8 THOC2 DIS3 PPP4R3A RRP12 NUP133 NIPBL WDR62 HSP90AA1	1.08e-05	934	184	17	33916271
Pubmed	Large-scale concatenation cDNA sequencing.	KIF1A TMEM94 USP9X NTRK3 EXOC3 MCM7 DIS3 VPS13D NUDT3 ITSN2 NUP133 WDFY3 PACSIN2	1.17e-05	568	184	13	9110174
Pubmed	An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation.	SIN3A NCOR1 HDAC2	1.20e-05	9	184	3	12007404
Pubmed	Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.	SIN3A NCOR1 HDAC2	1.20e-05	9	184	3	19244234
Pubmed	SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors.	SIN3A NCOR1 HDAC2	1.20e-05	9	184	3	9702189
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MYO1C MYO5A DHX37 ECD LAMA3 MCM7 HEATR1 ZFC3H1 NDUFA10 PRPF8 THOC2 APOBEC3B LRCH3 SRGAP1 SIPA1L1 RRP12 SMARCA1 NUP133 PLEC HSP90AA1	1.26e-05	1257	184	20	36526897
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	CUL2 TTF2 CAND1 MYO1C ACADM DHX37 USP9X MCM7 BTAF1 NDUFA10 PRPF8 THOC2 DIS3 OPA1 TAF6L NCOR1 SARS2 NUP133 HSP90AA1 HDAC2	1.26e-05	1257	184	20	37317656
Pubmed	A "double adaptor" method for improved shotgun library construction.	KIF1A TMEM94 USP9X NTRK3 EXOC3 MCM7 DIS3 VPS13D NUDT3 ITSN2 NUP133 WDFY3 PACSIN2	1.30e-05	574	184	13	8619474
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYO1C TRIO MYO5A BTAF1 PRPF8 TMTC3 RRP12 PLEC	1.32e-05	202	184	8	33005030
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TTF2 EDC3 RPGRIP1L TRIO DHX37 TTLL5 ECD CFI NCOR1 SIPA1L1 ITSN2 CEP135 RASEF PLEC WDR62 HSP90AA1	1.37e-05	853	184	16	28718761
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	DHX37 USP9X TBC1D2B RIPK2 EXOC3 NUP214 PRPF8 OPA1 VPS13D KIF2B RRP12 NAV2	1.51e-05	497	184	12	36774506
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TRPM4 ATP6V1C1 EDC3 CAND1 KIF1A MYO5A CHD7 HEATR1 ZFC3H1 NDUFA10 N4BP3 GRSF1 LRCH3 TAF6L TMEM120A KIDINS220 PIK3C2A SIPA1L1 RRP12 ITSN2 EXOC2 NIPBL	1.55e-05	1497	184	22	31527615
Pubmed	SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.	ERCC4 DHX37 NDUFA10 TAF6L RRP12 HSP90AA1 CDK3	1.61e-05	150	184	7	30154076
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	EDC3 ERF KALRN USP9X THOC2 NCOR1 RRP12 NUP133 NAV2 MAP2K2 NIPBL CDK3	1.70e-05	503	184	12	16964243
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	LRRC8E ERCC4 ZNF329 SREBF1 MCM7 SIN3A HEATR1 ZFC3H1 PRPF8 GOSR2 THOC2 APOBEC3B RLF TMTC3 RRP12 UQCC1 LSS PLEC RUSF1	2.32e-05	1203	184	19	29180619
Pubmed	Human transcription factor protein interaction networks.	CUL2 ERCC4 EDC3 ERF MYO1C MYO5A DHX37 USP9X CHD7 NUP214 SIN3A BAP1 RLF TAF6L NCOR1 KANSL2 RRP12 SMARCA1 NIPBL PACSIN2 HDAC2	2.45e-05	1429	184	21	35140242
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	CUL2 EDC3 CAND1 MYO1C ACADM DYNC2H1 NUP214 NDUFA10 PRPF8 N4BP3 DIS3 BAP1 TAF6L SARS2 PIK3C2A SIPA1L1 PLEC	2.73e-05	1005	184	17	19615732
Pubmed	Genetic interactions between BANK1 and BLK in Chinese patients with systemic lupus erythematosus.	BLK BANK1	2.78e-05	2	184	2	24085759
Pubmed	Identification of Serhl, a new member of the serine hydrolase family induced by passive stretch of skeletal muscle in vivo.	SERHL2 SERHL	2.78e-05	2	184	2	11352564
Pubmed	Multi-cancer V-ATPase molecular signatures: A distinctive balance of subunit C isoforms in esophageal carcinoma.	ATP6V1C1 ATP6V1C2	2.78e-05	2	184	2	31901859
Pubmed	Sodium channel TRPM4 and sodium/calcium exchangers (NCX) cooperate in the control of Ca2+-induced mucin secretion from goblet cells.	TRPM4 MUC5AC	2.78e-05	2	184	2	30482841
Pubmed	Interaction analysis between BLK rs13277113 polymorphism and BANK1 rs3733197 polymorphism, MMEL1/TNFRSF14 rs3890745 polymorphism in determining susceptibility to rheumatoid arthritis.	BLK BANK1	2.78e-05	2	184	2	28925718
Pubmed	Interaction between plasminogen activator inhibitor type-2 and pre-mRNA processing factor 8.	PRPF8 SERPINB2	2.78e-05	2	184	2	15346200
Pubmed	IκBNS induces Muc5ac expression in epithelial cells and causes airway hyper-responsiveness in murine asthma models.	NFKBID MUC5AC	2.78e-05	2	184	2	27878831
Pubmed	Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration.	CFI HMCN1	2.78e-05	2	184	2	25986072
Pubmed	The thyroid axis is regulated by NCoR1 via its actions in the pituitary.	NDOR1 NCOR1	2.78e-05	2	184	2	22878400
Pubmed	Human autoantibodies to a novel Golgi protein golgin-67: high similarity with golgin-95/gm 130 autoantigen.	GOLGA8B GOLGA8A	2.78e-05	2	184	2	10677249
Pubmed	Epinephrine Activation of the β2-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells.	ADRB2 MUC5AC	2.78e-05	2	184	2	26161982
Pubmed	Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.	TRIO KALRN	2.78e-05	2	184	2	26858404
Pubmed	The molecular motor Myosin Va interacts with the cilia-centrosomal protein RPGRIP1L.	RPGRIP1L MYO5A	2.78e-05	2	184	2	28266547
Pubmed	Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysis.	BLK BANK1	2.78e-05	2	184	2	23646104
Pubmed	Unveiling a novel serpinB2-tripeptidyl peptidase II signaling axis during senescence.	TPP2 SERPINB2	2.78e-05	2	184	2	35466366
Pubmed	Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK.	BLK BANK1	2.78e-05	2	184	2	21978998
Pubmed	Whole-exome sequence analysis highlights the role of unmasked recessive mutations in copy number variants with incomplete penetrance.	NUP214 NCOR1	2.78e-05	2	184	2	29483668
Pubmed	Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.	EPHX2 TRPC6	2.78e-05	2	184	2	18725458
Pubmed	Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.	ICAM1 SERPINB2	2.78e-05	2	184	2	28817461
Pubmed	Human Digital Meissner Corpuscles Display Immunoreactivity for the Multifunctional Ion Channels Trpc6 and Trpv4.	TRPC6 TRPV4	2.78e-05	2	184	2	27874267
Pubmed	Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria.	KALRN CHD7	2.78e-05	2	184	2	28152519
Pubmed	Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin.	SREBF1 PRKCB	2.78e-05	2	184	2	20179320
Pubmed	TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6.	TRPC6 TRPV4	2.78e-05	2	184	2	38338818
Pubmed	The SLE variant Ala71Thr of BLK severely decreases protein abundance and binding to BANK1 through impairment of the SH3 domain function.	BLK BANK1	2.78e-05	2	184	2	26821283
Pubmed	BLK and BANK1 variants and interactions are associated with susceptibility for primary Sjögren's syndrome and with some clinical features.	BLK BANK1	2.78e-05	2	184	2	33756160
Pubmed	Iron-inhibited autophagy via transcription factor ZFP27 in Parkinson's disease.	ZNF585A ZNF585B	2.78e-05	2	184	2	37668106
Pubmed	Regulation of PIDD auto-proteolysis and activity by the molecular chaperone Hsp90.	PIDD1 HSP90AA1	2.78e-05	2	184	2	20966961
Pubmed	BLK and BANK1 polymorphisms and interactions are associated in Mexican patients with systemic lupus erythematosus.	BLK BANK1	2.78e-05	2	184	2	31134304
Pubmed	Novel autosomal recessive LAMA3 and PLEC variants underlie junctional epidermolysis bullosa generalized intermediate and epidermolysis bullosa simplex with muscular dystrophy in two consanguineous families.	LAMA3 PLEC	2.78e-05	2	184	2	29797489
Pubmed	Identification and characterization of a novel Golgi protein, golgin-67.	GOLGA8B GOLGA8A	2.78e-05	2	184	2	10660574
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CAND1 MYO5A USP9X EXOC3 MCM7 BTAF1 NUP214 HEATR1 PRPF8 THOC2 TAF6L SACS RRP12 NUP133 PLEC NIPBL HDAC2	3.44e-05	1024	184	17	24711643
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	TPP2 CAND1 USP9X PRPF8 VPS13D SIPA1L1 PLEC HSP90AA1	3.88e-05	235	184	8	30258100
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CUL2 MYO5A DYNC2H1 TTLL5 ECD EXOC3 HEATR1 ZFC3H1 PRPF8 GOSR2 GRSF1 SARS2 KIDINS220 TMTC3 SACS PIK3C2A RRP12 NUP133 LSS PACSIN2 WDR62	4.36e-05	1487	184	21	33957083
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	TRIO MYO5A NDUFA10 LRCH3 EHD2 FSIP2 NUDT3 PRKCB UQCC1 MAP2K2 PACSIN2 HSP90AA1	4.65e-05	558	184	12	35063084
Pubmed	WDR62 is required for centriole duplication in spermatogenesis and manchette removal in spermiogenesis.	TDRD5 PIWIL1 RFX2 WDR62	4.86e-05	38	184	4	34059773
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	TPP2 TTF2 DNAH3 CAND1 MYO1C USP9X ECD MCM7 PRPF8 THOC2 PPP4R3A PLEC NIPBL HSP90AA1 HDAC2	4.92e-05	847	184	15	35235311
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TTF2 MYH7 ID1 BTAF1 SIN3A HEATR1 PRPF8 RFX2 BAP1 NCOR1 KANSL2 SMARCA1 NUP133 HSP90AA1 HDAC2	5.62e-05	857	184	15	25609649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EDC3 TRIO NTRK3 RIPK2 N4BP3 FSIP2 VPS13D PIK3C2A SRGAP1 SIPA1L1 NAV2 PLEC MAP2K2 WDR62 CDK3	5.92e-05	861	184	15	36931259
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	TPP2 MYH7 CAND1 DYNC2H1 CYP27C1 MARCHF6 SREBF1 PIDD1 MPZL2	5.93e-05	322	184	9	26514267
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	EDC3 RPGRIP1L TTLL5 TBC1D2B NCOR1 PIK3C2A SIPA1L1	5.94e-05	184	184	7	32908313
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	TTF2 ACADM DHX37 CYP27C1 MCM7 ZFC3H1 PRPF8 THOC2 GRSF1 RRP12 HSP90AA1	6.14e-05	486	184	11	30940648
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	SREBF1 NUP133 PLEC ARHGEF37 PACSIN2 HDAC2	6.42e-05	128	184	6	23858473
Pubmed	A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1.	SIN3A NCOR1 HDAC2	7.75e-05	16	184	3	11013263
Pubmed	CAND1 enhances deneddylation of CUL1 by COP9 signalosome.	CUL2 CAND1 HSP90AA1	7.75e-05	16	184	3	16036220
Pubmed	Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis.	SIN3A HDAC2	8.32e-05	3	184	2	24763403
Pubmed	TRPC1 and TRPC6 channels cooperate with TRPV4 to mediate mechanical hyperalgesia and nociceptor sensitization.	TRPC6 TRPV4	8.32e-05	3	184	2	19439599
Pubmed	Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action.	TRIO KALRN	8.32e-05	3	184	2	31801062
Pubmed	Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action.	NDOR1 NCOR1	8.32e-05	3	184	2	31404087
Pubmed	G-quadruplexes in the BAP1 promoter positively regulate its expression.	CHD7 BAP1	8.32e-05	3	184	2	29787736
Pubmed	A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression.	SIN3A NCOR1	8.32e-05	3	184	2	9139820
Pubmed	TDRD5 binds piRNA precursors and selectively enhances pachytene piRNA processing in mice.	TDRD5 PIWIL1	8.32e-05	3	184	2	29317670
Pubmed	Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection.	IFNAR1 CCR5	8.32e-05	3	184	2	31644426
Pubmed	TRPV4 channels are essential for alveolar epithelial barrier function as protection from lung edema.	TRPC6 TRPV4	8.32e-05	3	184	2	32931478
Pubmed	Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus.	BLK BANK1	8.32e-05	3	184	2	31101814
Cytoband	22q13.1-q13.2	APOBEC3B SGSM3	9.54e-05	4	184	2	22q13.1-q13.2
Cytoband	19q13.12	ZNF585A NFKBID ZNF585B WDR62	2.08e-04	72	184	4	19q13.12
GeneFamily	Small G protein signaling modulators	SGSM1 SGSM3	1.60e-04	3	133	2	751
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	HEATR1 APOBEC3B ARHGDIB NUP133	5.35e-04	51	133	4	870
GeneFamily	Neuroblastoma breakpoint family	NBPF4 NBPF6 NBPF5P	6.19e-04	23	133	3	662
GeneFamily	Transient receptor potential cation channels	TRPM4 TRPC6 TRPV4	1.11e-03	28	133	3	249
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO KALRN ITSN2 ARHGEF37	1.42e-03	66	133	4	722
GeneFamily	Exocyst complex	EXOC3 EXOC2	1.87e-03	9	133	2	1055
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	SIN3A HDAC2	1.87e-03	9	133	2	1306
GeneFamily	CD molecules\|C-C motif chemokine receptors	CCR5 CCR8	2.33e-03	10	133	2	1091
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	SIN3A HDAC2	3.38e-03	12	133	2	1243
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CUL2 CAND1 TRIO USP9X MARCHF6 ID1 BTAF1 THOC2 OPA1 RLF KIDINS220 SACS PIK3C2A SIPA1L1 ITSN2 CEP135 SERPINB2 SMARCA1 NUP133 WDFY3 NIPBL	6.42e-07	856	183	21	M4500
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHD7 PPP4R3A BLK RHOBTB2 GOLGA8B GOLGA8A CCDC191 BANK1	3.53e-07	160	184	8	7ad065337ac802de52c15ee715f6b78a3eed0cef
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO1C TRIO NFKBID BLK SIPA1L1 PRKCB CCDC191 BANK1	4.06e-07	163	184	8	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO1C TRIO NFKBID BLK SIPA1L1 PRKCB CCDC191 BANK1	6.39e-07	173	184	8	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	MYO1C ICAM1 LAMA3 ALS2CL ABCA8 EHD2 RHOBTB2 RASEF	6.97e-07	175	184	8	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBID PYHIN1 BLK ARHGDIB HAAO PRKCB IL4I1 BANK1	9.76e-07	183	184	8	20f7b6ec2462032eda957a893ca76d5a5a01333d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ICAM1 ID1 LAMA3 RFX2 ALS2CL ADRB2 NAV2 GOLGA8B	1.29e-06	190	184	8	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C NFKBID PYHIN1 EHD2 BLK IL4I1 RUBCN BANK1	1.35e-06	191	184	8	10644258b97f9c99eb0e199b64b970f6b986aa41
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C NFKBID PYHIN1 EHD2 BLK IL4I1 RUBCN BANK1	1.35e-06	191	184	8	408942fc8db939239aeee6ae07a21362133c9e2e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO1C NFKBID CHD7 BLK SIPA1L1 PRKCB RUBCN BANK1	1.51e-06	194	184	8	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C NFKBID PYHIN1 BLK PRKCB IL4I1 RUBCN BANK1	1.57e-06	195	184	8	d77423d0ec64b397c6d1eec181c5fc0acaa92d63
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C NFKBID PYHIN1 BLK PRKCB IL4I1 RUBCN BANK1	1.57e-06	195	184	8	f5bf4797972185afa76638293166abd536e5472f
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1C ICAM1 LAMA3 ALS2CL EHD2 RHOBTB2 NAV2 GOLGA8A	1.63e-06	196	184	8	eb68f7954e7c2f86d05e740e95b6e74805a6053f
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANO4 DNAH3 RPGRIP1L DPY19L2 DYNC2H1 SANBR LMLN CCDC191	1.70e-06	197	184	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Biopsy_IPF-Epithelial-AT1\|Biopsy_IPF / Sample group, Lineage and Cell type	LAMA3 ALS2CL ABCA8 EHD2 ADRB2 RHOBTB2 GOLGA8B GOLGA8A	1.76e-06	198	184	8	75bdecbe111fededf6082b11de18b84ca308ef6d
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-B_memory\|COVID-19_Severe / Disease, condition lineage and cell class	MYO1C NFKBID CHD7 N4BP3 AK8 BLK RHOBTB2 BANK1	1.83e-06	199	184	8	24c05faa825c9d55279956469862440f9914a280
ToppCell	Lymphoid-B_cells\|World / shred on cell class and cell subclass (v4)	PYHIN1 BLK ARHGDIB HAAO PRKCB IL4I1 BANK1	2.68e-06	147	184	7	aa4486200c523f2c9d3bad7a14f1764c2d92076b
ToppCell	Influenza_Severe-B_memory\|World / Disease group and Cell class	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	5.10e-06	162	184	7	21eb96cd4fecd85dd6acbbc3760944fa1a7cff42
ToppCell	3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Lung / Manually curated celltypes from each tissue	ID1 MCM7 RFX2 NEK2 SERPINB2 WDR62 CDK3	5.31e-06	163	184	7	47300dec94dc66e965bf71fafff0a9fd24fae968
ToppCell	NS-critical-d_0-4-Lymphoid-B_cell\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RPGRIP1L CHD7 FSIP2 SACS RHOBTB2 GOLGA8B BANK1	7.27e-06	171	184	7	bd1ebd9037a740ad8c01c460d778b0973d8b56df
ToppCell	severe_influenza-B_memory\|World / disease group, cell group and cell class (v2)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	7.55e-06	172	184	7	0ff38f9431cec73250c580a6010cb7891a3fe3f1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICAM1 NFKBID BLK HAAO CCR8 IL4I1 BANK1	7.84e-06	173	184	7	7c5e4809205ce1a0a301c15442af00a2e2b9b301
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1C NFKBID BLK ARHGDIB PRKCB CCDC191 BANK1	7.84e-06	173	184	7	67c342295b8a06ce38e081ba74478c568917a396
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRRC8E MYH7 ICAM1 LAMA3 SLC44A4 SLC26A8 RASEF	8.45e-06	175	184	7	35fb7735dd3355476fe60404833cb60bd066bcf1
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRRC8E MYH7 ICAM1 LAMA3 SLC44A4 SLC26A8 RASEF	8.45e-06	175	184	7	442f261a3b2c4d2523f7d4089178f8c79cac2f0f
ToppCell	facs-GAT-Fat-3m-Lymphocytic\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBID CHD7 PYHIN1 BLK ARHGDIB PRKCB CCR8	8.77e-06	176	184	7	2e3f25a338842384517656d05776a52cbfc62b52
ToppCell	facs-GAT-Fat-3m-Lymphocytic-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBID CHD7 PYHIN1 BLK ARHGDIB PRKCB CCR8	8.77e-06	176	184	7	0823088bc6b19c7ad784d83c2ccdfae80611afab
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBID PYHIN1 BLK TAF6L ARHGDIB PRKCB BANK1	9.80e-06	179	184	7	69c74b2ff43b43653005807654953daf21f932ec
ToppCell	facs-Kidney-nan-18m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POT1 RIPK2 PYHIN1 BLK ARHGDIB RUBCN BANK1	9.80e-06	179	184	7	f4fd214a9865c635d8a744ce5e0eff45174d3de4
ToppCell	CD8+_Memory_T_cell-FLU-5\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	EPHX2 N4BP3 RFX2 CCR8 ATP6V1C2 MPZL2 GOLGA8A	9.80e-06	179	184	7	7f18dffa85285599662edbcd3f32ab42672bffb8
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DYNC2H1 SLC44A4 AK8 CLHC1 TEKT1 CES4A	9.80e-06	179	184	7	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	facs-Kidney-nan-18m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POT1 RIPK2 PYHIN1 BLK ARHGDIB RUBCN BANK1	9.80e-06	179	184	7	57d8d44a793314eec8f77030f4177bfe21d41652
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYHIN1 BLK ARHGDIB HAAO PRKCB RUBCN BANK1	1.05e-05	181	184	7	ce30724788d9b5c6dfa4f9f8d318c3d2565165ed
ToppCell	severe_influenza-B_memory\|severe_influenza / disease group, cell group and cell class (v2)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.05e-05	181	184	7	92e572c92109a6dae0f73138c57c3bbd2e0a2f36
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYHIN1 BLK ARHGDIB PRKCB IL4I1 RUBCN BANK1	1.05e-05	181	184	7	2c2b812cdd350271935d7007665c26093756ebee
ToppCell	droplet-Limb_Muscle-nan-24m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBID PYHIN1 BLK ARHGDIB HAAO PRKCB BANK1	1.09e-05	182	184	7	6946ab8d91fb8dce5af065f57a13659b8d97ed5c
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	SGSM1 KALRN VASN NTRK3 ZNF329 ZNF585B ADRB2	1.09e-05	182	184	7	ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-B_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PYHIN1 BLK ARHGDIB HAAO PRKCB RUBCN BANK1	1.17e-05	184	184	7	eb41dce59eb0384c1671fbc76eb15daab2c8c49a
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-B_cell-B_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PYHIN1 BLK ARHGDIB HAAO PRKCB RUBCN BANK1	1.17e-05	184	184	7	991500a874c5dd0d9111399520071da67bc6ac3d
ToppCell	Healthy/Control-B_memory\|World / Disease group and Cell class	NFKBID CHD7 N4BP3 AK8 BLK NAV2 BANK1	1.17e-05	184	184	7	9e1879d86b535ede9b47deb0752e291f987a5d5e
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBID PYHIN1 BLK ADRB2 HAAO PRKCB BANK1	1.21e-05	185	184	7	eb338fcda0b237c2e0b9b4b0daf51febbfe1d79c
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBID PYHIN1 BLK ADRB2 HAAO PRKCB BANK1	1.21e-05	185	184	7	c31bb53852caf36964b83b28bcaee07b679da779
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYHIN1 BLK ARHGDIB ADRB2 PRKCB IL4I1 BANK1	1.26e-05	186	184	7	6b2d15e2756d4d4d68ad600e4a6c074edc3488f2
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYHIN1 BLK ARHGDIB ADRB2 PRKCB IL4I1 BANK1	1.26e-05	186	184	7	a8fcb440d88770f95678c5d28413fc4d847f42a8
ToppCell	facs-MAT-Fat-18m-Lymphocytic-B_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYHIN1 BLK ARHGDIB HAAO PRKCB IL4I1 BANK1	1.26e-05	186	184	7	cee9faec3fb7baa56c87592fb166d32d0bf8fe94
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO1C ICAM1 LAMA3 ALS2CL NAV2 GOLGA8B GOLGA8A	1.30e-05	187	184	7	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	APOBEC3B TAF6L RRP12 SERPINB2 HAAO ZFYVE26 WDR62	1.30e-05	187	184	7	3c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell	facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC6 RFX2 SACS SMARCA1 UQCC1 LSS GOLGA8A	1.30e-05	187	184	7	f1e9877d859369b862d4a559ec9ab9be74a67a96
ToppCell	facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC6 RFX2 SACS SMARCA1 UQCC1 LSS GOLGA8A	1.30e-05	187	184	7	3ffbd50b49059dcd3e23c5ac01901e4352142446
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ICAM1 LAMA3 ALS2CL NAV2 GOLGA8B RASEF GOLGA8A	1.35e-05	188	184	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	Healthy/Control-B_memory\|Healthy/Control / Disease group and Cell class	NFKBID CHD7 N4BP3 AK8 BLK NAV2 BANK1	1.35e-05	188	184	7	3aff07f77b2b15e7a30e47b30115178abe64474e
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHX2 ICAM1 HID1 ARHGDIB FRRS1 HMCN1 MPZL2	1.44e-05	190	184	7	6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO1C TRIO NFKBID AK8 BLK PRKCB BANK1	1.44e-05	190	184	7	0db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCell	COVID-19_Severe-Lymphoid_B-B_memory\|COVID-19_Severe / Disease group, lineage and cell class	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.44e-05	190	184	7	b6510c419a15ed049c0a0a6a6697b643668741c3
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.49e-05	191	184	7	22134a2c1a92208bc1629a620ce73a56502613c2
ToppCell	severe_COVID-19-B_memory\|World / disease group, cell group and cell class (v2)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.49e-05	191	184	7	3b57e353b74ebc866d0e11deeba31fa764c42325
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C PYHIN1 EHD2 BLK PRKCB IL4I1 BANK1	1.49e-05	191	184	7	9502533a7946626e1714a22a0f16c70d296edf16
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C PYHIN1 BLK PRKCB IL4I1 RUBCN BANK1	1.54e-05	192	184	7	2de242d81dc085ae734eb7d1f091af9a542e0866
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_memory\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.54e-05	192	184	7	72f936f03bb9b58c1ccaaf8270c07f5bbf2ac355
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.54e-05	192	184	7	debd471f61cf3606b8e9c246add0be5df601af7f
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C PYHIN1 BLK PRKCB IL4I1 RUBCN BANK1	1.54e-05	192	184	7	ba2a683472a8b785dbf666dc6e94356d879486c3
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.54e-05	192	184	7	314f74dd3c6d94839eed05b9a1a398217ef78029
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MYO1C LAMA3 ALS2CL ABCA8 EHD2 ADRB2 GOLGA8A	1.54e-05	192	184	7	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	droplet-Spleen-SPLEEN-1m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C EHD2 BLK ARHGDIB ADRB2 PRKCB BANK1	1.54e-05	192	184	7	9b8191e66626919cad2c63349c8ef61e9792fcf5
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANO4 ICAM1 ID1 ZFC3H1 PIK3C2A PRKCB HSP90AA1	1.54e-05	192	184	7	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_memory-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.54e-05	192	184	7	dac61f0b374f6f9476eedce97f341f26c1bc037c
ToppCell	COVID-19_Mild-Lymphoid_B-B_memory\|COVID-19_Mild / Disease group, lineage and cell class	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.54e-05	192	184	7	d27db7669de95bddbea8ccb83e6f10ae7240b1ab
ToppCell	mild_COVID-19-B_memory\|World / disease group, cell group and cell class (v2)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.60e-05	193	184	7	69b70c838328fdc7dbb6b5449fe2811a5389a839
ToppCell	facs-Heart-RV-18m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERHL N4BP3 SARS2 ADRB2 LSS ACCSL MPZL2	1.60e-05	193	184	7	77bc4353a1e9eae32bc6beb333577ba0294a10fc
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO1C TRIO NFKBID N4BP3 AK8 BLK BANK1	1.60e-05	193	184	7	de0213f2105b814f38ffbfd004ea7603230eed68
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO1C NFKBID CHD7 BLK SIPA1L1 PRKCB BANK1	1.60e-05	193	184	7	f4135615ee0118eec9e221becdd67888e0c2a112
ToppCell	facs-Heart-RV-18m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERHL N4BP3 SARS2 ADRB2 LSS ACCSL MPZL2	1.60e-05	193	184	7	b9b431c18c81c616069a546cded4753563a1e701
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO1C NFKBID CHD7 BLK SIPA1L1 PRKCB BANK1	1.60e-05	193	184	7	ac227ddabfb3f021b1b39dba73f898517cd5a58e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 RPGRIP1L DYNC2H1 SANBR SLC44A4 CES4A CCDC191	1.65e-05	194	184	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	AT1_cells\|World / lung cells shred on cell class, cell subclass, sample id	MYO1C ICAM1 LAMA3 ALS2CL ABCA8 EHD2 GOLGA8A	1.71e-05	195	184	7	792d6a49b0a875a00569071183d195287a9925c5
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1C ICAM1 LAMA3 ABCA8 EHD2 GOLGA8B GOLGA8A	1.76e-05	196	184	7	6731fef8c148b6681d6ed38afdf23c8213e0bbbe
ToppCell	Epithelial_cells-AT1_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	MYO1C ICAM1 LAMA3 ALS2CL ABCA8 EHD2 GOLGA8A	1.76e-05	196	184	7	6c99d29162848161c1f166a032320f87a5d5a631
ToppCell	severe_COVID-19-B_memory\|severe_COVID-19 / disease group, cell group and cell class (v2)	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.76e-05	196	184	7	c6e00cb59a88b9903cca233cefe05f80c5ea4153
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1C ICAM1 LAMA3 ABCA8 EHD2 GOLGA8B GOLGA8A	1.76e-05	196	184	7	6856317cd0cdcb88fe54b4ae905d91e13495b1c4
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 SLC44A4 AK8 NAV2 TEKT1 RASEF	1.76e-05	196	184	7	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	AT1_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	MYO1C ICAM1 LAMA3 ALS2CL ABCA8 EHD2 GOLGA8A	1.82e-05	197	184	7	80d81be244c94c435accb643449b4ce6a3462c7f
ToppCell	normal_Lung-Epithelial_cells-AT1\|Epithelial_cells / Location, Cell class and cell subclass	MYO1C LAMA3 ALS2CL ABCA8 EHD2 GOLGA8B GOLGA8A	1.82e-05	197	184	7	7d19b93d6853828e2a036e37c4887edb1de4503c
ToppCell	ASK428-Epithelial-Type_1\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYO1C ICAM1 LAMA3 ALS2CL ABCA8 EHD2 NAV2	1.82e-05	197	184	7	9ae6661c307791c3f0ecd3d378e3d917565e5498
ToppCell	ASK428-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	MYO1C LAMA3 ALS2CL ABCA8 EHD2 ADRB2 NAV2	1.88e-05	198	184	7	0047a9ef7684230ac5179efea94461480e90bdaf
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B-B_memory\|Influenza_Severe / Disease, condition lineage and cell class	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.94e-05	199	184	7	bf0285f68c9cb1417fc070abc3cb224d07407e0e
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory\|COVID-19_Mild / Disease, condition lineage and cell class	MYO1C NFKBID CHD7 N4BP3 AK8 BLK BANK1	1.94e-05	199	184	7	54e392b4ebe601d4838739ff7de3ac6b2203c948
ToppCell	control-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZNF717 ID1 ALS2CL NEK2 THBS3 SMARCA1 CES4A	1.94e-05	199	184	7	50e2da35edff1aadef939cfbd4549f73c1a07717
ToppCell	Biopsy_Control_(H.)-Epithelial-AT1\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	LAMA3 ALS2CL ABCA8 EHD2 ADRB2 GOLGA8B GOLGA8A	2.01e-05	200	184	7	3a9633f5913f12b6865fc777c84f3f3ba795a78d
ToppCell	PND07-28-samps-Lymphocyte-B_cell-B_cell_2\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CLHC1 PYHIN1 BLK CEP135 PRKCB BANK1	2.27e-05	137	184	6	2544d1256f11da6e3bad24a871b2253e0ab20d01
ToppCell	PND07-28-samps-Lymphocyte-B_cell\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CLHC1 PYHIN1 BLK CEP135 PRKCB BANK1	2.27e-05	137	184	6	874e2eaa7846a2832f46b77c726d79f220a4a1cd
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFKBID BLK HAAO PRKCB IL4I1 BANK1	4.71e-05	156	184	6	44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DPY19L2 PRTFDC1 HMCN1 ABCA6 NAV2 GOLGA8A	4.71e-05	156	184	6	4d2679e7639758c49fc25a2deb9109b08f0a3e57
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH3 RPGRIP1L NTRK3 FASTKD1 PYHIN1 SACS	4.71e-05	156	184	6	a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFKBID BLK HAAO PRKCB IL4I1 BANK1	4.71e-05	156	184	6	55ba43cec9d79f309e9f633a6469cf03bb621e64
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BLK RHOBTB2 PRKCB LSS IL4I1 BANK1	5.24e-05	159	184	6	74655c22e9fdd88e3052b9dfb954c8fb678bd2d8
ToppCell	normal_Pleural_Fluid-B_lymphocytes-Undetermined\|normal_Pleural_Fluid / Location, Cell class and cell subclass	NFKBID CHD7 AK8 BLK PRKCB BANK1	5.43e-05	160	184	6	5744cd30709f38e84f7ec8893dc19d7a288b465a
ToppCell	Immune_cells-B_cell\|World / Lineage and Cell class	NFKBID BLK ARHGDIB PRKCB IL4I1 BANK1	6.02e-05	163	184	6	3a02465de7c2f7cea227e289fb082a1fb6400301
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRC8E VASN HID1 SLC44A4 SERPINB2 MUC5AC	6.22e-05	164	184	6	c5bfae7e9497185548c243d6f9ebadbcef48ba7f
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRC8E VASN HID1 SLC44A4 SERPINB2 MUC5AC	6.22e-05	164	184	6	76b0ac220b7ca22fbea28a507f01f96ae9f53932
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRC8E VASN HID1 SLC44A4 SERPINB2 MUC5AC	6.22e-05	164	184	6	911081739174ec68bc0893c804e4276b206bea7d
ToppCell	facs-Heart-RA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BLK ARHGDIB HAAO PRKCB IL4I1 BANK1	6.44e-05	165	184	6	36415924d05373e9dd3665be599f4f3f40bf0497
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A	EPHX2 KIF1A TTLL5 ICAM1 TBC1D2B BFSP1 EHD2 VPS13D SIPA1L1 WDFY3 RUSF1	5.42e-07	195	183	11	5455_DN
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A	SERHL2 DNAH3 RPGRIP1L TRIO BFSP1 ARHGDIB VPS13D RRP12 SGSM3 WDR62 CDK3	5.42e-07	195	183	11	6626_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; MCF7; HT_HG-U133A	TRPM4 ATP6V1C1 ERCC4 DSCAM TRIO PPP4R3A RRP12 NAV2 WDFY3 RUSF1 CDK3	6.96e-07	200	183	11	7170_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	LRRC8E ERCC4 ID1 ZFC3H1 PPP4R3A LRCH3 TAF6L UQCC1 ZFYVE26 PLEC	2.28e-06	182	183	10	947_DN
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A	DSCAM KIF1A ZNF329 RIPK2 N4BP3 GOSR2 ALS2CL VPS13D SIPA1L1 HAAO	4.23e-06	195	183	10	7361_UP
Drug	Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A	SERHL2 ERCC4 PIDD1 VPS13D RHOBTB2 CEP135 SERPINB2 WDFY3 RUSF1 WDR62	4.63e-06	197	183	10	5800_DN
Drug	Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	CUL2 DYNC2H1 TMEM94 TTLL5 ZNF329 PIDD1 GRSF1 PPP4R3A VPS13D WDR62	4.63e-06	197	183	10	5536_DN
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A	EPHX2 SERHL2 C14orf93 ERF TRIO SREBF1 GOSR2 ACAN SLC35A2 NIPBL	4.84e-06	198	183	10	6681_DN
Drug	Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A	DNAH3 DSCAM MARCHF6 PIDD1 THBS3 KIDINS220 CEP135 NAV2 WDFY3 RUBCN	4.84e-06	198	183	10	3450_DN
Drug	Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A	MYO1C DYNC2H1 ICAM1 THBS3 GPN2 SIPA1L1 ZFYVE26 SGSM3 PLEC CDK3	4.84e-06	198	183	10	1316_DN
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	LRRC8E TRPM4 C14orf93 ATP6V1C1 RPGRIP1L TRIO GOSR2 IFNAR1 ARHGDIB PLEC	4.84e-06	198	183	10	4979_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; PC3; HT_HG-U133A	SERHL2 NDOR1 ERF KIF1A PIDD1 NUP214 PYHIN1 KIDINS220 SGSM3 CDK3	4.84e-06	198	183	10	6332_UP
Drug	16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	SERHL2 DSCAM GOSR2 ARHGDIB VPS13D SLC35A2 LSS SGSM3 MPZL2 MUC5AC	4.84e-06	198	183	10	7541_UP
Drug	Nepl	ECD MAP2K2 HSP90AA1	1.75e-05	7	183	3	CID006439214
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A	DYNC2H1 TTLL5 ICAM1 RLF THBS3 ADRB2 RHOBTB2 LSS RUSF1	2.05e-05	186	183	9	2426_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A	GOSR2 LRCH3 THBS3 ADRB2 PIK3C2A SERPINB2 LSS WDFY3 CDK3	2.63e-05	192	183	9	2919_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRPM4 KIF1A TRIO ICAM1 UQCC1 SGSM3 WDFY3 WDR62 CDK3	2.74e-05	193	183	9	5239_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A	DSCAM TTLL5 LAMA3 GOSR2 RRP12 LSS SGSM3 RUSF1 CDK3	2.97e-05	195	183	9	2223_DN
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A	SERHL2 ATP6V1C1 DSCAM TTLL5 ALS2CL ARHGDIB VPS13D NAV2 PLEC	2.97e-05	195	183	9	5330_UP
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A	DSCAM TRIO ICAM1 NUP214 ALS2CL VPS13D LSS SGSM3 MPZL2	2.97e-05	195	183	9	2761_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DYNC2H1 TMEM94 TTLL5 DIS3 THBS3 SIPA1L1 RRP12 SLC35A2 MPZL2	3.10e-05	196	183	9	7022_DN
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	NDOR1 ICAM1 MARCHF6 PIDD1 ALS2CL SLC35A2 COA1 HAAO WDFY3	3.10e-05	196	183	9	3360_UP
Drug	Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A	NDOR1 RFX2 PYHIN1 ACAN CEP135 PRKCB TRPV4 LSS CCR8	3.10e-05	196	183	9	4407_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	TRPM4 ERF RFX2 IFNAR1 TAF6L ACAN RRP12 HAAO LSS	3.10e-05	196	183	9	3783_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; HL60; HG-U133A	NTRK3 PIDD1 NUP214 GOSR2 PPP4R3A LRCH3 ACAN RRP12 RUSF1	3.10e-05	196	183	9	2019_UP
Drug	AH6809; Down 200; 1uM; PC3; HT_HG-U133A	C14orf93 DNAH3 ATP6V1C1 ERF DSCAM TTLL5 PLEC RUSF1 CDK3	3.10e-05	196	183	9	7049_DN
Drug	Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; HL60; HT_HG-U133A	C14orf93 TBC1D2B RIPK2 PIDD1 GOSR2 ALS2CL SLC35A2 SGSM3 RUBCN	3.22e-05	197	183	9	2379_DN
Drug	celecoxib; Down 200; 10uM; PC3; HG-U133A	EPHX2 DNAH3 DSCAM NTRK3 SREBF1 EHD2 ARHGDIB RUSF1 CDK3	3.22e-05	197	183	9	482_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; HL60; HT_HG-U133A	TTLL5 BAP1 PYHIN1 RRP12 SLC35A2 HAAO SGSM3 PLEC WDR62	3.22e-05	197	183	9	2205_DN
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	DNAH3 RPGRIP1L DSCAM GOSR2 BAP1 LRCH3 THBS3 RHOBTB2 SGSM3	3.22e-05	197	183	9	2796_DN
Drug	Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	SERHL2 NDOR1 DSCAM NUP214 ALS2CL EHD2 SIPA1L1 RHOBTB2 WDFY3	3.22e-05	197	183	9	7334_UP
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	TRPM4 KIF1A TRIO TTLL5 NCOR1 THBS3 ACAN SIPA1L1 MUC5AC	3.22e-05	197	183	9	7514_UP
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	CUL2 ERCC4 KIF1A ICAM1 GOSR2 VPS13D METTL25B SGSM3 WDFY3	3.22e-05	197	183	9	2845_DN
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A	ATP6V1C1 TTLL5 ICAM1 NUP214 GOSR2 ARHGDIB RHOBTB2 LSS CDK3	3.22e-05	197	183	9	2265_DN
Drug	Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	LRRC8E ATP6V1C1 NDOR1 ICAM1 NUP214 ALS2CL VPS13D CEP135 LSS	3.22e-05	197	183	9	7350_UP
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	CUL2 TRPM4 DSCAM KIF1A DYNC2H1 TTLL5 N4BP3 BFSP1 VPS13D	3.35e-05	198	183	9	6497_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	DNAH3 EDC3 MYO1C PIDD1 GOSR2 KIDINS220 CEP135 SGSM3 CDK3	3.35e-05	198	183	9	1332_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	EPHX2 ICAM1 BFSP1 PPP4R3A LRCH3 NCOR1 ARHGDIB SIPA1L1 WDFY3	3.35e-05	198	183	9	2297_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	TRPM4 ICAM1 PIDD1 DIS3 BFSP1 VPS13D LSS SGSM3 CDK3	3.35e-05	198	183	9	5582_DN
Drug	Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A	CUL2 C14orf93 ERCC4 TRIO ICAM1 TBC1D2B LAMA3 PPP4R3A SIPA1L1	3.35e-05	198	183	9	5361_UP
Drug	Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A	TTF2 DIS3 THBS3 RHOBTB2 NAV2 ZFYVE26 PLEC RUSF1 CDK3	3.35e-05	198	183	9	2809_DN
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	SERHL2 DSCAM ICAM1 LAMA3 PIDD1 GOSR2 DIS3 SGSM3 CDK3	3.35e-05	198	183	9	7506_DN
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	SERHL2 TRIO KALRN TBC1D2B ARHGDIB ACAN SLC35A2 PLEC WDR62	3.49e-05	199	183	9	5927_UP
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A	TRPM4 DSCAM TAF6L NCOR1 VPS13D SIPA1L1 SLC35A2 SGSM3 MPZL2	3.49e-05	199	183	9	7020_DN
Drug	Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	MAGEA8 C14orf93 TMEM94 TTLL5 ARHGDIB VPS13D SLC35A2 WDR62 CDK3	3.49e-05	199	183	9	6272_UP
Drug	Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; HL60; HT_HG-U133A	ICAM1 CHD7 OPA1 RLF VPS13D ADRB2 COA1 WDFY3	1.12e-04	181	183	8	2957_DN
Drug	Frie Mao 1-43	TRPM4 MYO5A TRPC6 EXOC3 NUP214	1.31e-04	61	183	5	CID002733618
Drug	Ketotifen	ICAM1 SREBF1 ADRB2	1.38e-04	13	183	3	ctd:D007665
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	TRIO TTLL5 ICAM1 N4BP3 GOSR2 METTL25B SIPA1L1 PLEC	1.62e-04	191	183	8	5200_DN
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A	C14orf93 ATP6V1C1 ERCC4 KIF1A GOSR2 VPS13D SGSM3 PLEC	1.62e-04	191	183	8	3888_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	ERF TMEM94 PIDD1 GOSR2 ADRB2 SGSM3 NIPBL RUSF1	1.62e-04	191	183	8	7376_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A	SERHL2 ICAM1 NUP214 KIDINS220 CEP135 SMARCA1 PRKCB MUC5AC	1.74e-04	193	183	8	3370_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	TBC1D2B GOSR2 TAF6L THBS3 METTL25B CEP135 PLEC RUSF1	1.80e-04	194	183	8	6893_DN
Drug	5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA	EDC3 DYNC2H1 TTLL5 GOSR2 VPS13D ZFYVE26 SGSM3 WDFY3	1.80e-04	194	183	8	862_UP
Drug	CP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A	C14orf93 ATP6V1C1 ERCC4 GOSR2 DIS3 TAF6L LSS PLEC	1.80e-04	194	183	8	7522_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A	LAMA3 BFSP1 BAP1 TAF6L VPS13D RHOBTB2 SGSM3 CDK3	1.80e-04	194	183	8	5454_DN
Drug	Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ATP6V1C1 RPGRIP1L N4BP3 DIS3 IFNAR1 TAF6L KIDINS220 PRKCB	1.80e-04	194	183	8	3308_UP
Drug	ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A	ERCC4 MYO1C TBC1D2B PIDD1 ADRB2 SGSM3 PLEC RUBCN	1.80e-04	194	183	8	1179_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	CUL2 SERHL2 THBS3 VPS13D RRP12 NAV2 LSS WDR62	1.80e-04	194	183	8	5303_UP
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	CUL2 C14orf93 ICAM1 TBC1D2B ALS2CL VPS13D SIPA1L1 RHOBTB2	1.87e-04	195	183	8	4748_DN
Drug	Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A	DSCAM TBC1D2B GOSR2 DIS3 THBS3 SLC35A2 LSS SGSM3	1.87e-04	195	183	8	1514_DN
Drug	Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	DSCAM PIDD1 BFSP1 ARHGDIB VPS13D SIPA1L1 RHOBTB2 COA1	1.87e-04	195	183	8	5631_DN
Drug	carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	EPHX2 SERHL2 DNAH3 KIF1A TRIO TTLL5 ZNF329 WDR62	1.87e-04	195	183	8	919_UP
Drug	5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	EPHX2 DNAH3 MYH7 TRIO DIS3 VPS13D RRP12 MUC5AC	1.87e-04	195	183	8	920_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	KIF1A ICAM1 NUP214 TAF6L SIPA1L1 SLC35A2 CEP135 SGSM3	1.87e-04	195	183	8	6224_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	C14orf93 RPGRIP1L KIF1A TRIO IFNAR1 THBS3 CEP135 CDK3	1.87e-04	195	183	8	4975_DN
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	RPGRIP1L TTLL5 TBC1D2B TAF6L THBS3 LSS SGSM3 WDR62	1.87e-04	195	183	8	3323_DN
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A	LRRC8E RPGRIP1L DSCAM KIF1A GOSR2 THBS3 METTL25B PLEC	1.87e-04	195	183	8	4947_DN
Drug	5,6-epoxy-8,11,14-eicosatrienoic acid	EPHX2 TRPV4	1.92e-04	3	183	2	ctd:C040776
Drug	Gleevec; Up 200; 10uM; MCF7; HG-U133A	DSCAM TRIO NUP214 GOSR2 EHD2 ACAN RRP12 RUSF1	1.94e-04	196	183	8	366_UP
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	EPHX2 DNAH3 ATP6V1C1 RPGRIP1L RRP12 SLC35A2 LSS WDFY3	1.94e-04	196	183	8	5425_DN
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A	INPP5A ICAM1 NCOR1 METTL25B SLC35A2 LSS SGSM3 WDR62	1.94e-04	196	183	8	5288_UP
Drug	Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A	TTLL5 ICAM1 GOSR2 ALS2CL SLC35A2 WDFY3 WDR62 CDK3	1.94e-04	196	183	8	2473_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A	CUL2 DYNC2H1 TBC1D2B VPS13D HAAO PLEC BANK1 WDR62	1.94e-04	196	183	8	2737_DN
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; HL60; HG-U133A	TTF2 ERCC4 MYO1C MARCHF6 PIDD1 ACAN SERPINB2 NIPBL	1.94e-04	196	183	8	1399_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	SERHL2 EDC3 NCOR1 METTL25B RRP12 SGSM3 WDFY3 CDK3	1.94e-04	196	183	8	5765_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CUL2 TRIO DYNC2H1 GOSR2 DIS3 SGSM3 MPZL2 WDR62	1.94e-04	196	183	8	3206_DN
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A	RPGRIP1L NUP214 GOSR2 ALS2CL PPP4R3A EHD2 VPS13D COA1	1.94e-04	196	183	8	1497_UP
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A	C14orf93 DSCAM TRIO LAMA3 PIDD1 N4BP3 GRSF1 OPA1	1.94e-04	196	183	8	5007_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; HL60; HT_HG-U133A	MYO1C DYNC2H1 TTLL5 NUP214 VPS13D SLC35A2 SGSM3 RUBCN	1.94e-04	196	183	8	2496_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CUL2 ATP6V1C1 DSCAM DYNC2H1 TTLL5 VPS13D SLC35A2 PLEC	1.94e-04	196	183	8	1685_DN
Drug	Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A	C14orf93 NTRK3 PPP4R3A NCOR1 KIDINS220 RRP12 SLC35A2 WDR62	1.94e-04	196	183	8	7167_UP
Drug	Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	LRRC8E TRPM4 PIDD1 TAF6L ARHGDIB SIPA1L1 LSS CDK3	1.94e-04	196	183	8	5686_DN
Drug	quercetin 3-O-glucuronide	ACADM ICAM1 SREBF1 ADRB2	1.95e-04	36	183	4	ctd:C443401
Drug	Riboflavine [83-88-5]; Up 200; 10.6uM; HL60; HG-U133A	ERF TBC1D2B PIDD1 VPS13D RRP12 SLC35A2 SGSM3 PLEC	2.00e-04	197	183	8	1767_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A	TRPM4 ATP6V1C1 MARCHF6 PIDD1 GOSR2 SLC35A2 LSS SGSM3	2.00e-04	197	183	8	3838_DN
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; HL60; HG-U133A	ERF MYO1C ICAM1 PIDD1 LRCH3 NCOR1 UQCC1 RUBCN	2.00e-04	197	183	8	1621_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	DSCAM PPP4R3A EHD2 ARHGDIB VPS13D SIPA1L1 RHOBTB2 WDFY3	2.00e-04	197	183	8	5436_DN
Drug	Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	TBC1D2B LAMA3 TAF6L THBS3 VPS13D RRP12 LSS CDK3	2.00e-04	197	183	8	2765_DN
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A	DSCAM TTLL5 NUP214 GOSR2 DIS3 PPP4R3A METTL25B CDK3	2.00e-04	197	183	8	3549_DN
Drug	Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	CUL2 TRPM4 C14orf93 NDOR1 ICAM1 SLC35A2 CEP135 LSS	2.00e-04	197	183	8	7169_UP
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	CUL2 DSCAM TTLL5 ICAM1 TBC1D2B NCOR1 COA1 WDFY3	2.00e-04	197	183	8	4751_DN
Drug	15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	KIF1A TRIO TTLL5 ICAM1 PIDD1 RFX2 VPS13D MUC5AC	2.00e-04	197	183	8	7521_UP
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	EDC3 DSCAM TTLL5 GOSR2 THBS3 VPS13D METTL25B SGSM3	2.00e-04	197	183	8	6957_DN
Drug	Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; HL60; HT_HG-U133A	EDC3 MYO1C KIF1A SIPA1L1 SLC35A2 SGSM3 WDFY3 RUBCN	2.00e-04	197	183	8	2412_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A	C14orf93 NDOR1 DSCAM KIF1A CHD7 CFI PYHIN1 ACAN	2.00e-04	197	183	8	4299_UP
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; PC3; HT_HG-U133A	ICAM1 PIDD1 TAF6L VPS13D METTL25B RHOBTB2 SLC35A2 CEP135	2.00e-04	197	183	8	5801_DN
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	TRPM4 C14orf93 TTLL5 SREBF1 ALS2CL TAF6L SLC35A2 LSS	2.00e-04	197	183	8	6077_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	NDOR1 ERCC4 NUP214 GOSR2 ARHGDIB RRP12 SLC35A2 WDFY3	2.00e-04	197	183	8	6222_UP
Drug	Etodolac [41340-25-4]; Down 200; 14uM; MCF7; HT_HG-U133A	ERCC4 ICAM1 PIDD1 NUP214 PYHIN1 VPS13D SIPA1L1 WDR62	2.00e-04	197	183	8	2254_DN
Disease	Malignant neoplasm of breast	ACADM KALRN DYNC2H1 NUP214 RFX2 ALS2CL APOBEC3B BAP1 NCOR1 THBS3 SIPA1L1 ITSN2 SLC35A2 SERPINB2 NUP133 ACCS UQCC1 ZFYVE26 NIPBL RUSF1 HSP90AA1	2.31e-06	1074	178	21	C0006142
Disease	Peripheral Nervous System Diseases	ERCC4 MYO5A ICAM1 RHOBTB2 SERPINB2	1.88e-05	54	178	5	C4721453
Disease	glutamine conjugate of C7H12O2 measurement	ACADM SLC44A5	3.62e-05	2	178	2	EFO_0800656
Disease	glutamine conjugate of C6H10O2 (2) measurement	ACADM SLC44A5	3.62e-05	2	178	2	EFO_0800658
Disease	acetylcarnitine-to-hexanoylcarnitine ratio	ACADM SLC44A5	3.62e-05	2	178	2	EFO_0021514
Disease	caproate 6:0 measurement	ACADM SLC44A5	3.62e-05	2	178	2	EFO_0021102
Disease	caprylate 8:0 measurement	ACADM SLC44A5	3.62e-05	2	178	2	EFO_0021103
Disease	cancer (implicated_via_orthology)	ERCC4 CAND1 SIN3A BLK NEK2 MAP2K2 NIPBL HSP90AA1 CDK3	3.90e-05	268	178	9	DOID:162 (implicated_via_orthology)
Disease	cups of coffee per day measurement	EDC3 HECTD4 SLC44A4 ATP1A4	9.87e-05	40	178	4	EFO_0006782
Disease	4-methylhexanoylglutamine measurement	ACADM SLC44A5	1.08e-04	3	178	2	EFO_0800576
Disease	(S)-3-hydroxybutyrylcarnitine measurement	ACADM SLC44A5	1.08e-04	3	178	2	EFO_0800475
Disease	kidney disease (implicated_via_orthology)	TRPC6 BLK ADRB2 LCTL	1.09e-04	41	178	4	DOID:557 (implicated_via_orthology)
Disease	psoriasis (is_marker_for)	ICAM1 CFI ADRB2 CCR5	1.44e-04	44	178	4	DOID:8893 (is_marker_for)
Disease	hexanoylglutamine measurement	ACADM SLC44A5	2.15e-04	4	178	2	EFO_0800262
Disease	X-23680 measurement	ACADM SLC44A5	2.15e-04	4	178	2	EFO_0800862
Disease	glaucoma (is_marker_for)	ID1 CCR5 MUC5AC	2.28e-04	20	178	3	DOID:1686 (is_marker_for)
Disease	Cis-4-decenoyl carnitine measurement	ACADM SLC44A5	3.58e-04	5	178	2	EFO_0022091
Disease	decenoylcarnitine measurement	ACADM SLC44A5	3.58e-04	5	178	2	EFO_0021803
Disease	sleep efficiency	GOLGA8B GOLGA8A	3.58e-04	5	178	2	EFO_0803364
Disease	suberoylcarnitine (C8-DC) measurement	ACADM SLC44A5	3.58e-04	5	178	2	EFO_0800382
Disease	congestive heart failure (biomarker_via_orthology)	MYH7 OPA1 ADRB2 ACAN PRKCB	4.88e-04	107	178	5	DOID:6000 (biomarker_via_orthology)
Disease	age at menopause	PIWIL1 CHD7 SLC44A4 OPA1 AK8 SLC26A8 MAP2K2 IL4I1	5.21e-04	302	178	8	EFO_0004704
Disease	disease of metabolism (is_implicated_in)	SREBF1 ADRB2	5.34e-04	6	178	2	DOID:0014667 (is_implicated_in)
Disease	Tumor of Rete Testis	ERCC4 BAP1	5.34e-04	6	178	2	C1720811
Disease	nonanoylcarnitine (C9) measurement	ACADM SLC44A5	5.34e-04	6	178	2	EFO_0800381
Disease	transient cerebral ischemia (implicated_via_orthology)	TRPC6 SIN3A OPA1 PTPN5	6.13e-04	64	178	4	DOID:224 (implicated_via_orthology)
Disease	Microcephaly	NUP214 SIN3A LSS WDR62	7.30e-04	67	178	4	C0025958
Disease	Malignant neoplasm of testis	ERCC4 BAP1	7.45e-04	7	178	2	C0153594
Disease	hexanoylglycine measurement	ACADM SLC44A5	7.45e-04	7	178	2	EFO_0800233
Disease	immature granulocyte measurement	CHD7 PRTFDC1	7.45e-04	7	178	2	EFO_0803543
Disease	focal segmental glomerulosclerosis (implicated_via_orthology)	TRPC6 SRGAP1	7.45e-04	7	178	2	DOID:1312 (implicated_via_orthology)
Disease	Squamous cell carcinoma	ERCC4 INPP5A APOBEC3B PRTFDC1 HDAC2	9.53e-04	124	178	5	C0007137
Disease	urticaria (is_implicated_in)	ADRB2 CCR5	9.89e-04	8	178	2	DOID:1555 (is_implicated_in)
Disease	Testicular Neoplasms	ERCC4 BAP1	9.89e-04	8	178	2	C0039590
Disease	cis-4-decenoylcarnitine (C10:1) measurement	ACADM SLC44A5	9.89e-04	8	178	2	EFO_0800311
Disease	androsterone sulfate measurement	NTRK3 FAM200A MAP2K2	1.03e-03	33	178	3	EFO_0021117
Disease	Heart Failure, Diastolic	MYH7 WDR45 SIPA1L1	1.03e-03	33	178	3	C1135196
Disease	psoriasis (is_implicated_in)	ICAM1 ADRB2 BANK1	1.13e-03	34	178	3	DOID:8893 (is_implicated_in)
Disease	ulcerative colitis (biomarker_via_orthology)	ICAM1 ADRB2	1.27e-03	9	178	2	DOID:8577 (biomarker_via_orthology)
Disease	octanoylcarnitine measurement	ACADM SLC44A5	1.27e-03	9	178	2	EFO_0021042
Disease	X-18921 measurement	ACADM SLC44A5	1.27e-03	9	178	2	EFO_0800796
Disease	cis-4-decenoate (10:1n6) measurement	ACADM SLC44A5	1.27e-03	9	178	2	EFO_0800318
Disease	egg allergy measurement	ERCC4 SERPINB2	1.27e-03	9	178	2	EFO_0007018
Disease	proteinuria (biomarker_via_orthology)	ICAM1 TRPC6	1.58e-03	10	178	2	DOID:576 (biomarker_via_orthology)
Disease	familial hypercholesterolemia (is_implicated_in)	EPHX2 ADRB2	1.58e-03	10	178	2	DOID:13810 (is_implicated_in)
Disease	dry eye syndrome (is_marker_for)	CCR5 MUC5AC	1.58e-03	10	178	2	DOID:10140 (is_marker_for)
Disease	eosinophil count	CUL2 DNAH3 ZNF585A POT1 HECTD4 SREBF1 CHD7 THOC2 AK8 PRTFDC1 ZNF585B ADRB2 RRP12 NUP133 PRKCB EXOC2 PLEC MAP2K2 MUC5AC	1.70e-03	1488	178	19	EFO_0004842
Disease	myeloid white cell count	ERF MYO1C ICAM1 TRPC6 HECTD4 SREBF1 CHD7 FAM200A PRTFDC1 KANSL2 ADRB2 CES4A ATP1A4 MAP2K2	1.71e-03	937	178	14	EFO_0007988
Disease	Familial Atypical Mole Melanoma Syndrome	POT1 BAP1	1.92e-03	11	178	2	C2314896
Disease	X-21607 measurement	ACADM SLC44A5	1.92e-03	11	178	2	EFO_0800819
Disease	Cutaneous Melanoma	ERCC4 BAP1 MAP2K2	1.94e-03	41	178	3	C0151779
Disease	nervous system disease (implicated_via_orthology)	KIF1A ATP1A4	2.30e-03	12	178	2	DOID:863 (implicated_via_orthology)
Disease	hexanoylcarnitine measurement	ACADM SLC44A5	2.30e-03	12	178	2	EFO_0021040
Disease	decanoylcarnitine measurement	ACADM SLC44A5	2.30e-03	12	178	2	EFO_0021039
Disease	Neurodevelopmental Disorders	DSCAM TRIO WDR45 WDFY3	2.46e-03	93	178	4	C1535926
Disease	intercellular adhesion molecule 5 measurement	ICAM1 ABCA6	2.70e-03	13	178	2	EFO_0008164
Disease	glutaroyl carnitine measurement	ACADM SLC44A5	2.70e-03	13	178	2	EFO_0021005
Disease	rhinitis (biomarker_via_orthology)	OPA1 MUC5AC	2.70e-03	13	178	2	DOID:4483 (biomarker_via_orthology)
Disease	Hereditary Motor and Sensory-Neuropathy Type II	KIF1A TRPV4	2.70e-03	13	178	2	C0270914
Disease	chronic obstructive pulmonary disease (is_marker_for)	ICAM1 ADRB2 CCR5 MUC5AC	2.87e-03	97	178	4	DOID:3083 (is_marker_for)
Disease	wet macular degeneration	SLC44A4 CFI	3.14e-03	14	178	2	EFO_0004683
Disease	diffuse large B-cell lymphoma	ITSN2 EXOC2	3.14e-03	14	178	2	EFO_0000403
Disease	pulmonary fibrosis (biomarker_via_orthology)	ICAM1 CCR8 MUC5AC	3.44e-03	50	178	3	DOID:3770 (biomarker_via_orthology)
Disease	memory performance	ANO4 ERCC4 RPGRIP1L NTRK3 HEATR1 PRPF8 EXOC2 BANK1	3.52e-03	409	178	8	EFO_0004874
Disease	HIV Infections	PRPF8 ARHGDIB ADRB2 HSP90AA1	3.56e-03	103	178	4	C0019693
Disease	HIV Coinfection	PRPF8 ARHGDIB ADRB2 HSP90AA1	3.56e-03	103	178	4	C4505456
Disease	myelodysplastic syndrome (implicated_via_orthology)	PRPF8 BAP1	3.61e-03	15	178	2	DOID:0050908 (implicated_via_orthology)
Disease	Autosomal recessive primary microcephaly	CEP135 WDR62	3.61e-03	15	178	2	cv:C3711387
Disease	teratocarcinoma-derived growth factor 1 measurement	MYO5A ALS2CL	4.11e-03	16	178	2	EFO_0008297
Disease	Rolandic epilepsy	DPY19L2 KALRN	4.11e-03	16	178	2	Orphanet_1945
Disease	Prostatic Neoplasms	TRPM4 ERF ICAM1 CHD7 BAP1 PYHIN1 NCOR1 ADRB2 ITSN2 SMARCA1	4.37e-03	616	178	10	C0033578
Disease	Malignant neoplasm of prostate	TRPM4 ERF ICAM1 CHD7 BAP1 PYHIN1 NCOR1 ADRB2 ITSN2 SMARCA1	4.37e-03	616	178	10	C0376358
Disease	neutrophil measurement	ICAM1 CHD7 ADRB2 RRP12 PLEC	4.49e-03	177	178	5	EFO_0803548
Disease	urate measurement, bone density	ERCC4 DSCAM INPP5A TRPC6 SLC44A4 ABCA8 FSIP2 SLC26A8 KIDINS220 RHOBTB2	4.52e-03	619	178	10	EFO_0003923, EFO_0004531
Disease	immature granulocyte count	SLC44A4 PRTFDC1	4.64e-03	17	178	2	EFO_0803542
Disease	Familial Progressive Myoclonic Epilepsy	GOSR2 SACS	4.64e-03	17	178	2	C0751777
Disease	Atypical Inclusion-Body Disease	GOSR2 SACS	4.64e-03	17	178	2	C0751776
Disease	Myoclonic Epilepsies, Progressive	GOSR2 SACS	4.64e-03	17	178	2	C0751778
Disease	Biotin-Responsive Encephalopathy	GOSR2 SACS	4.64e-03	17	178	2	C0751780
Disease	May-White Syndrome	GOSR2 SACS	4.64e-03	17	178	2	C0751782
Disease	Dentatorubral-Pallidoluysian Atrophy	GOSR2 SACS	4.64e-03	17	178	2	C0751781
Disease	Age-related macular degeneration	CFI HMCN1	5.20e-03	18	178	2	cv:C0242383
Disease	respiratory syncytial virus infectious disease (is_marker_for)	ICAM1 CCR5	5.20e-03	18	178	2	DOID:1273 (is_marker_for)
Disease	Action Myoclonus-Renal Failure Syndrome	GOSR2 SACS	5.20e-03	18	178	2	C0751779
Disease	schizophrenia, inflammatory bowel disease	PRKCB BANK1	5.20e-03	18	178	2	EFO_0003767, MONDO_0005090
Disease	asthma (biomarker_via_orthology)	ICAM1 CCR8 MUC5AC	5.48e-03	59	178	3	DOID:2841 (biomarker_via_orthology)
Disease	schizophrenia, sex interaction measurement	DSCAM NDUFA10 ABCA6	5.74e-03	60	178	3	EFO_0008343, MONDO_0005090
Disease	pulmonary non-tuberculous mycobacterial infection	COA1 PRKCB	5.78e-03	19	178	2	MONDO_0018469
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	BAP1 HSP90AA1	5.78e-03	19	178	2	DOID:4928 (is_marker_for)
Disease	chronic lymphocytic leukemia	POT1 EXOC2 MAP2K2 BANK1	5.93e-03	119	178	4	EFO_0000095
Disease	Intellectual Disability	TRIO TMEM94 SIN3A SACS RHOBTB2 SLC35A2 LSS WDR62	5.96e-03	447	178	8	C3714756
Disease	pancreatic ductal carcinoma (is_marker_for)	NTRK3 MCM7 MUC5AC	6.01e-03	61	178	3	DOID:3587 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
IIHRVLEKQEVEVFY	TDRD5	546	Q8NAT2
EFAKRYNLHVIIDEI	ACCSL	346	Q4AC99
ALYLTEVFLHVVKRE	BANK1	41	Q8NDB2
EVFLHVVKREAILLY	BANK1	46	Q8NDB2
LLIYVVSRARIQHLG	ALS2CL	886	Q60I27
HFILELLRKEEYQGV	ERF	31	P50548
HVIQDNLIRKEVYIL	ADRB2	296	P07550
HPDLKRIVIEYVDRI	CFI	401	P05156
VYREIVKNLGERHVP	CYP27C1	376	Q4G0S4
ENYAFLHRTLKEILR	APOBEC3B	176	Q9UH17
KHRDVVIRQGEIFLL	HAAO	71	P46952
EYLVFAKRHRLHVIV	ACCS	271	Q96QU6
LVDTYRKEPELQRHI	ARHGEF37	131	A1IGU5
DLVKRARLVRVHAYI	EHD2	296	Q9NZN4
LREHLEVYAAVKGLR	ABCA6	1371	Q8N139
YEARLHVLKVNRQTV	BAP1	241	Q92560
IQRLIVAREHIDKYK	ACADM	406	P11310
SRIVHHILQRIKYEE	ANO4	261	Q32M45
RYLAVVHAVFALKAR	CCR5	126	P51681
YRIELLRKIREQVLH	CHD7	2056	Q9P2D1
LRNEIYIFLVEKQSH	FAM200A	316	Q8TCP9
HKEILQKYIERIITR	ECD	31	O95905
AVLRGLAYLREKHQI	MAP2K2	176	P36507
LRQAEELRQYKALVH	NBPF4	86	Q96M43
YVLIPHGIIVDRIER	PRTFDC1	41	Q9NRG1
RLIQPYEHVIKNFIR	RASEF	161	Q8IZ41
YEHVIKNFIREIRLQ	RASEF	166	Q8IZ41
IERKRQGYIHELIQT	ITSN2	1206	Q9NZM3
VQKVIHTEDYRLRLI	PTPN5	426	P54829
HIKNYIINKDILRRV	PPP4R3A	526	Q6IN85
ALLKHREEIGNRYIE	GRSF1	306	Q12849
SRVIFQLKAERDYHI	MYH7	271	P12883
QVYLDGIVRILRHRQ	KIAA0895L	391	Q68EN5
TVIIRQHEIVLKVAY	NUP133	776	Q8WUM0
KVEILQHVIDYIRDL	ID1	91	P41134
HVEIVRALLQKYADI	KIDINS220	281	Q9ULH0
LELIDQLRKHIEYRL	LRCH3	656	Q96II8
RHYRQLNEKLVQLIE	GPN2	216	Q9H9Y4
YVKVLEHVVRVNARV	MAGEA8	286	P43361
LRLRIPQVGHYVVVV	LAMA3	946	Q16787
ELKHPNIVRYYDRII	NEK2	61	P51955
LKVEQYVHLLDIRAA	RPGRIP1L	546	Q68CZ1
PDTYVQHIKRRDIVL	NTRK3	526	Q16288
VLQVYRRLDIREHKG	NFKBID	71	Q8NI38
RDNKIVRHTVYLLVT	LMLN	331	Q96KR4
YKSLIQHLEEIRVLV	DDX60L	211	Q5H9U9
LNKLYQRVREVTGHL	FSIP2	2491	Q5CZC0
HLYNETKVRKELIRE	CAND1	1051	Q86VP6
VEERIENIYSRHKIY	IFNAR1	176	P17181
AQKLLEYHRNIVRVI	AK8	216	Q96MA6
RNYLKEALVNIIAVH	EXOC2	796	Q96KP1
RHKALGYVLDRIIDQ	INPP5A	206	Q14642
YKVQEDIILLRELHV	LCTL	91	Q6UWM7
NQERKHRTYVYVLIV	NUDT3	86	O95989
HYIYVVRILREGQIE	PIK3C2A	1441	O00443
EKVVLVFLQHRLGIF	CES4A	161	Q5XG92
YKAARHLEVRIQDFV	KALRN	616	O60229
LRQRAVQKLYEHIVA	LSS	311	P48449
VFSRYEKHRQLILEE	NIPBL	1441	Q6KC79
GIRNIDLHYIVRKLA	MARCHF6	796	O60337
LQEIRRLHQYVKFAV	NUP214	811	P35658
IIIVIVVVLFQHYRK	MPZL2	166	O60487
ARLRVDQLKYDVQHL	GOSR2	66	O14653
RIYIQAHIDRDVLIV	PRKCB	161	P05771
QIAYVPEHVRKLRSL	LRRC8E	641	Q6NSJ5
PRSIILEYHQDRVVL	MUC5AC	4976	P98088
LEYHQDRVVLTRKPV	MUC5AC	4981	P98088
RVHELKIEEYVQRGL	METTL25B	366	Q96FB5
IVYRRIIVPHNVSKE	EDC3	256	Q96F86
NAIKRFHLYPEVIIA	DPY19L2	186	Q6NUT2
RLNDELLHYILKIVV	HECTD4	401	Q9Y4D8
KVYVQHRLRELGSLV	NDOR1	521	Q9UHB4
QLVRLAHREQVALYV	MCM7	36	P33993
LYHLRLLVQDKFEVL	NDUFA10	291	O95299
LEVVVKGIVFHYRAI	ACAN	146	P16112
RSKDYRLTHEVLQLI	HMCN1	146	Q96RW7
ELLHTQLKYQRILER	OPA1	221	O60313
LRFFREVLLEVQKHL	PACSIN2	241	Q9UNF0
LLDVVHNERKLYLVF	CDK3	66	Q00526
YYKKELERLQHIIQR	CEP135	456	Q66GS9
LKVHYSDRLVILLRE	DYNC2H1	571	Q8NCM8
YVTVKPRVRLHFVEL	EPHX2	241	P34913
HRIGQKRVVNVYRLI	BTAF1	1741	O14981
ELNLRIKYIIDHFTL	DNAH3	3341	Q8TD57
EYRVKIHFKVNRDIV	ARHGDIB	106	P52566
RYLAVVHAVYALKVR	CCR8	131	P51685
LEVHAYRLSRKVEIL	FRRS1	531	Q6ZNA5
LQHERLVRLYAVVTK	BLK	291	P51451
TLKNELDRYHRIIEI	BFSP1	301	Q12934
LLHVIYQRVDKAVGL	C14orf93	61	Q9H972
LEAIAKEHYERVLLR	CCDC191	736	Q8NCU4
KKRHLEILGYRVIQI	FASTKD1	801	Q53R41
TDGQFYLLIRKRIHL	GABARAPL3	56	Q9BY60
LKGLEVINDYHFRIV	PYHIN1	11	Q6K0P9
RLYTETKIFLENHVR	CUL2	56	Q13617
QRYGVEALLHRQLKE	KANSL2	266	Q9H9L4
LVQIARVILEYIDHK	SLC44A4	511	Q53GD3
RVILEYIDHKLRGVQ	SLC44A4	516	Q53GD3
IVLEYLDHRLKRTQN	SLC44A5	531	Q8NCS7
HVRIERLVIQSYFVQ	HSPB11	56	Q9Y547
LPYHETRIFVRVIQL	HEATR1	136	Q9H583
LIHKNQTRELRVLYG	ICAM1	381	P05362
LVTKRHQQILLYIDF	CYP4F3	231	Q08477
AFVERLRKHGLEVIY	HSP90AA1	506	P07900
REHVEKLELGFIQYR	GOLGA8B	431	A8MQT2
VRHLEIIRKYVLDDL	EXOC3	276	O60645
DIVLAILELLKYHQR	HDAC2	156	Q92769
FLLLRYKVVIIDEAH	DHX37	361	Q8IY37
QHADIYKLRIRVRGN	RUBCN	676	Q92622
LLTYKRRAIEHVLQV	SERHL2	146	Q9H4I8
VAENVYRLKHLLLEI	SACS	3051	Q9NZJ4
HYLKLIDRENFVDIV	COA1	71	Q9GZY4
YVAIQRSDKRIHLAV	KIF2B	31	Q8N4N8
QEVEKTRHYLLLREK	KIF1A	1386	Q12756
VALHLGVSYREVQRI	PIDD1	806	Q9HB75
QEALRRLHYVPATKV	IL4I1	341	Q96RQ9
QFKLEEHYELRSILR	SERPINB2	311	P05120
QRQREVGRLIDYIHK	PIWIL1	416	Q96J94
LLTYKRRAIEHVLQV	SERHL	146	Q9NQF3
VHIKAVLREPYTVRV	DSCAM	116	O60469
HVEKLELGFIQYRRE	GOLGA8A	461	A7E2F4
RLRLVLKHYLQRGEV	RUSF1	291	Q96GQ5
RKELVHLYPREAQLE	SARS2	146	Q9NP81
HKVYGAILVAVERLL	TAF6L	356	Q9Y6J9
RKEYNIGVLRHLQVI	USP9X	1636	Q93008
HVKALRVFVESVLRY	ATP6V1C1	296	P21283
HIKALRVFVESVLRY	ATP6V1C2	341	Q8NEY4
HAKQRIQEDYLRILR	TRNT1	186	Q96Q11
IDNLYERALHIRKLL	SRGAP1	606	Q7Z6B7
RYLVIDEAHRIKNEK	SMARCA1	306	P28370
IQETHRLYRLKLEEL	TMEM120A	26	Q9BXJ8
LRQAEELRQYKALVH	NBPF5P	86	Q86XG9
LRQAEELRQYKALVH	NBPF6	86	Q5VWK0
RQVLSHLRDKYVFIT	RDH16	21	O75452
VTLHDVKALQLVYRR	RFX2	361	P48378
VHYVDSRGLVVLRQI	SLC26A8	731	Q96RN1
VYAIIRKRSIFHQLA	HID1	551	Q8IV36
KHRSIVQIIYDENRK	NCOR1	231	O75376
GVVRRLFKEYIIHVD	NAV2	2056	Q8IVL1
GDIVRFHRLKIQVYK	POT1	76	Q9NUX5
VLQERVRIFAHKIYL	RHOBTB2	271	Q9BYZ6
VETQRRKHLAYLIAD	SGSM3	366	Q96HU1
VLHLDRVKRYIVEHV	SIPA1L1	471	O43166
SEVIHRKALQRIYAD	SIN3A	661	Q96ST3
LAYREKRIGIDLVHD	TEKT1	116	Q969V4
RHDKIVIVLKNRIYV	WDR45	111	Q9Y484
VDRRGNIVYIHIRDK	SANBR	351	Q6NSI8
RYADVIVHRLLAVAI	DIS3	781	Q9Y2L1
KRLLPEEYHRVLVNI	RRP12	1021	Q5JTH9
AHRRLKYISLAVLVV	SLC35A2	31	P78381
AVLRKAIDYIRFLQH	SREBF1	361	P36956
VRQHLEVYAAVKGLR	ABCA8	1376	O94911
VYDEIRKLLIRQHPD	ATP1A4	1006	Q13733
IIYRNVFDKVIEHIT	CLHC1	51	Q8NHS4
LRLTKLVVDSHVQYR	PRPF8	551	Q6P2Q9
FYVKVRLIEHQRIHT	ZNF157	451	P51786
EYTHIRNILIVLTKI	THOC2	1116	Q8NI27
EVHKRRYLLQPIAVE	WDFY3	2616	Q8IZQ1
LKQLHYLRPVVVLER	RLF	1876	Q13129
IVKLHEIRVRVRYQK	TMEM94	1326	Q12767
RFRILHEIALGVNYL	RIPK2	121	O43353
DVHVRLRQRIILYEL	TMC4	306	Q7Z404
LEKGDYTIRLQIRHE	TPP2	881	P29144
KAFTYRSELIIHQRI	ZNF585B	361	Q52M93
LYTVNLHRIEKDVQR	SGSM1	931	Q2NKQ1
DPRHLELLVEYVRKQ	UQCC1	241	Q9NVA1
QIALDYLRHRQVKLV	PLEC	241	Q15149
VLVRYQREDGKVHAV	THBS3	96	P49746
KAFTYRSELIIHQRI	ZNF585A	361	Q6P3V2
LERLYLGKNRIRHIQ	VASN	126	Q6EMK4
EHYSELLVQAVRRKA	WDR62	1501	O43379
EKLFVRNHTLLYIRE	ZNF717	681	Q9BY31
DLITGILVYRAHRII	ERCC4	126	Q92889
NRAVVKYSRLEDVLH	PLAAT5	176	Q96KN8
EYEIVHTLLRKGARI	TRPC6	231	Q9Y210
EYIQRHLNIVRDKIS	TMTC3	806	Q6ZXV5
LVVVNALLRKRRYHA	PXMP4	11	Q9Y6I8
RHREIQALYVGSKIL	ZFYVE26	1646	Q68DK2
KTFIESAYLIRHQRI	ZNF329	406	Q86UD4
RAYHLEKVRLELTEL	TBC1D2B	921	Q9UPU7
IVLKGQREVHRLYQR	ZFC3H1	1916	O60293
IERRCKHYVELLVAQ	TRPV4	246	Q9HBA0
QLGHIREYEQRLKVL	TRPM4	1161	Q8TD43
IRVIGERYHLSYKIV	TTLL5	56	Q6EMB2
SLKRRHYVLQELVET	TRIO	1966	O75962
KIRAHLGEVLEAVRY	TRIO	2891	O75962
RIYRVGQQKDVVIHR	TTF2	1101	Q9UNY4
KFNVHLQLERRLIYT	VPS13D	851	Q5THJ4
RFDEVLIRHQVKYLG	MYO1C	636	O00159
RYRKILREHKAVIIQ	MYO5A	856	Q9Y4I1
ELKRLYVERLHEVTQ	N4BP3	296	O15049